To develop and validate a CT image-based multiple time-series deep learning model for the longitudinal prediction of benign and malignant pulmonary ground-glass nodules (GGNs). A total of 486 GGNs from an equal number of patients were included in this research, which took place at two medical centers. Each nodule underwent surgical removal and was confirmed pathologically. The patients were randomly assigned to a training set, validation set, and test set, following a distribution ratio of 7:2:1. We established a transformer-based deep learning framework that leverages multi-temporal CT images for the longitudinal prediction of GGNs, focusing on distinguishing between benign and malignant types. Additionally, we utilized 13 different machine learning algorithms to formulate clinical models, delta-radiomics models, and combined models that merge deep learning with CT semantic features. The predictive capabilities of the models were assessed using the receiver operating characteristic (ROC) curve and the area under the curve (AUC). The multiple time-series deep learning model based on CT images surpassed both the clinical model and the delta-radiomics model, showcasing strong predictive capabilities for GGNs across the training, validation, and test sets, with AUCs of 0.911 (95% CI, 0.879-0.939), 0.809 (95% CI,0.715-0.908), and 0.817 (95% CI,0.680-0.937), respectively. Furthermore, the models that integrated deep learning with CT semantic features achieved the highest performance, resulting in AUCs of 0.960 (95% CI, 0.912-0.977), 0.878 (95% CI,0.801-0.942), and 0.890(95% CI, 0.790-0.968). The multiple time-series deep learning model utilizing CT images was effective in predicting benign and malignant GGNs.

Lung cancer remains the leading cause of cancer-related mortality worldwide, due to lacking effective early-stage screening approaches. Imaging, such as low-dose CT, poses radiation risk, and biopsies can induce some complications. Additionally, traditional serum tumor markers lack diagnostic specificity. This highlights the urgent need for precise and non-invasive early detection techniques. This systematic review aims to evaluate the limitations of conventional screening methods (imaging/biopsy/tumor markers), seek breakthroughs in liquid biopsy for early lung cancer detection, and assess the potential value of Artificial Intelligence (AI), thereby providing evidence-based insights for establishing an optimal screening framework. We systematically searched the PubMed database for the literature published up to May 2025. Key words include "Artificial Intelligence", "Early Lung cancer screening", "Imaging examination", "Innovative technologies", "Liquid biopsy", and "Puncture biopsy". Our inclusion criteria focused on studies about traditional and innovative screening methods, with an emphasis on original research concerning diagnostic performance or high-quality reviews. This approach helps identify critical studies in early lung cancer screening. Novel liquid biopsy techniques are non-invasive and have superior diagnostic efficacy. AI-assisted diagnostics further enhance accuracy. We propose three development directions: establishing risk-based liquid biopsy screening protocols, developing a stepwise "imaging-AI-liquid biopsy" diagnostic workflow, and creating standardized biomarker panel testing solutions. Integrating traditional methodologies, novel liquid biopsies, and AI to establish a comprehensive early lung cancer screening model is important. These innovative strategies aim to significantly increase early detection rates, substantially enhancing lung cancer control. This review provides both theoretical guidance for clinical practice and future research.

The skull has long been recognized and utilized in forensic investigations, evolving from basic to complex analyses with modern technologies. Advances in radiology and technology have enhanced the ability to analyze biological identifiers-sex, stature, and age at death-from the skull. The use of computed tomography imaging helps practitioners to improve the accuracy and reliability of forensic analyses. Recently, artificial intelligence has increasingly been applied in digital forensic investigations to estimate sex, stature, and age from computed tomography images. The integration of artificial intelligence represents a significant shift in multidisciplinary collaboration, offering the potential for more accurate and reliable identification, along with advancements in academia. However, it is not yet fully developed for routine forensic work, as it remains largely in the research and development phase. Additionally, the limitations of artificial intelligence systems, such as the lack of transparency in algorithms, accountability for errors, and the potential for discrimination, must still be carefully considered. Based on scientific publications from the past decade, this article aims to provide an overview of the application of computed tomography imaging in estimating sex, stature, and age from the skull and to address issues related to future directions to further improvement.

Transarterial Chemoembolization (TACE) is a widely applied alternative treatment for patients with hepatocellular carcinoma who are not eligible for liver resection or transplantation. However, the clinical outcomes after TACE are highly heterogeneous. There remains an urgent need for effective and efficient strategies to accurately assess tumor response and predict long-term outcomes using longitudinal and multi-center datasets. To address this challenge, we here introduce RECIST^Surv, a novel response-driven Transformer model that integrates multi-task learning with a response-driven co-attention mechanism to simultaneously perform liver and tumor segmentation, predict tumor response to TACE, and estimate overall survival based on longitudinal Computed Tomography (CT) imaging. The proposed Response-driven Co-attention layer models the interactions between pre-TACE and post-TACE features guided by the treatment response embedding. This design enables the model to capture complex relationships between imaging features, treatment response, and survival outcomes, thereby enhancing both prediction accuracy and interpretability. In a multi-center validation study, RECIST^Surv-predicted prognosis has demonstrated superior precision than state-of-the-art methods with C-indexes ranging from 0.595 to 0.780. Furthermore, when integrated with multi-modal data, RECIST^Surv has emerged as an independent prognostic factor in all three validation cohorts, with hazard ratio (HR) ranging from 1.693 to 20.7 (P = 0.001-0.042). Our results highlight the potential of RECIST^Surv as a powerful tool for personalized treatment planning and outcome prediction in hepatocellular carcinoma patients undergoing TACE. The experimental code is made publicly available at https://github.com/rushier/RECISTSurv.

The long-term association between adrenal gland volume (AGV) and type 2 diabetes (T2D) remains unclear. We aimed to determine the association between deep learning-based AGV and current glycemic status and incident T2D. In this observational study, adults who underwent abdominopelvic computed tomography (CT) for health checkups (2011-2012), but had no adrenal nodules, were included. AGV was measured from CT images using a three-dimensional nnU-Net deep learning algorithm. We assessed the association between AGV and T2D using a cross-sectional and longitudinal design. We used 500 CT scans (median age, 52.3 years; 253 men) for model development and a Multi-Atlas Labeling Beyond the Cranial Vault dataset for external testing. A clinical cohort included a total of 9708 adults (median age, 52.0 years; 5,769 men). The deep learning model demonstrated a dice coefficient of 0.71±0.11 for adrenal segmentation and a mean volume difference of 0.6± 0.9 mL in the external dataset. Participants with T2D at baseline had a larger AGV than those without (7.3 cm3 vs. 6.7 cm3 and 6.3 cm3 vs. 5.5 cm3 for men and women, respectively, all P<0.05). The optimal AGV cutoff values for predicting T2D were 7.2 cm3 in men and 5.5 cm3 in women. Over a median 7.0-year follow-up, T2D developed in 938 participants. Cumulative T2D risk was accentuated with high AGV compared with low AGV (adjusted hazard ratio, 1.27; 95% confidence interval, 1.11 to 1.46). AGV, measured using deep learning algorithms, is associated with current glycemic status and can significantly predict the development of T2D.

Despite advances in endovascular stroke therapy (EST) devices and techniques, many patients are left with substantial disability, even if the final infarct volumes (FIVs) remain small. Here, we evaluate the performance of a machine learning (ML) approach using pre-treatment CT angiography (CTA) to identify this cohort of patients that may benefit from additional interventions. We identified consecutive large vessel occlusion (LVO) acute ischemic stroke (AIS) subjects who underwent EST with successful reperfusion in a multicenter prospective registry cohort. We included only subjects with FIV<30mL and recorded 90-day outcome (modified Rankin scale, mRS). A deep learning model was pre-trained and then fine-tuned to predict 90-day mRS 0-2 using pre-treatment CTA images (DSN-CTA model). The primary outcome was the predictive performance of the DSNCTA model compared to a logistic regression model with clinical variables, measured by the area under the receiver operating characteristic curve (AUROC). The DSN-CTA model was pre-trained on 1,542 subjects and then fine-tuned and cross-validated with 48 subjects, all of whom underwent EST with TICI 2b-3 reperfusion. Of this cohort, 56.2% of subjects had 90-day mRS 3-6 despite successful EST and FIV<30mL. The DSN-CTA model showed significantly better performance than a model with clinical variables alone when predicting good 90-day mRS (AUROC 0.81 vs 0.492, p=0.006). The CTA-based machine learning model was able to more reliably predict unexpected poor functional outcome after successful EST and small FIV for patients with LVO AIS compared to standard clinical variables. ML models may identify <i>a priori</i> patients in whom EST-based LVO reperfusion alone is insufficient to improve clinical outcomes. AIS＝ acute ischemic stroke; AUROC＝ area under the receiver operating characteristic curve; DSN-CTA＝ DeepSymNet-v3 model; EST＝ endovascular stroke therapy; FIV＝ final infarct volume; LVO＝ large vessel occlusion; ML＝ machine learning.

This study explores a multi-modal deep learning approach that integrates pre-intervention neuroimaging and clinical data to predict endovascular therapy (EVT) outcomes in acute ischemic stroke patients. To this end, consecutive stroke patients undergoing EVT were included in the study, including patients with suspected Intracranial Atherosclerosis-related Large Vessel Occlusion ICAD-LVO and other refractory occlusions. A retrospective, single-center cohort of patients with anterior circulation LVO who underwent EVT between 2017-2023 was analyzed. Refractory LVO (rLVO) defined class, comprised patients who presented any of the following: final angiographic stenosis > 50 %, unsuccessful recanalization (eTICI 0-2a) or required rescue treatments (angioplasty +/- stenting). Neuroimaging data included non-contrast CT and CTA volumes, automated vascular segmentation, and CT perfusion parameters. Clinical data included demographics, comorbidities and stroke severity. Imaging features were encoded using convolutional neural networks and fused with clinical data using a DAFT module. Data were split 80 % for training (with four-fold cross-validation) and 20 % for testing. Explainability methods were used to analyze the contribution of clinical variables and regions of interest in the images. The final sample comprised 599 patients; 481 for training the model (77, 16.0 % rLVO), and 118 for testing (16, 13.6 % rLVO). The best model predicting rLVO using just imaging achieved an AUC of 0.53 ± 0.02 and F1 of 0.19 ± 0.05 while the proposed multimodal model achieved an AUC of 0.70 ± 0.02 and F1 of 0.39 ± 0.02 in testing. Combining vascular segmentation, clinical variables, and imaging data improved prediction performance over single-source models. This approach offers an early alert to procedural complexity, potentially guiding more tailored, timely intervention strategies in the EVT workflow.

Cone beam CT is an imaging modality that provides high-resolution, cross-sectional imaging in the fluoroscopy suite. In neuroradiology, cone beam CT has been used for various applications including temporal bone imaging and during spinal and cerebral angiography. Furthermore, cone beam CT has been shown to improve imaging of spinal CSF leaks during myelography. One drawback of cone beam CT is that images have a relatively high noise level. In this technical report, we describe the first application of a high-resolution convolutional neural network to denoise cone beam CT myelographic images. We show examples of the resulting improvement in image quality for a variety of types of spinal CSF leaks. Further application of this technique is warranted to demonstrate its clinical utility and potential use for other cone beam CT applications.ABBREVIATIONS: CBCT = cone beam CT; CB-CTM = cone beam CT myelography; CTA = CT angiography; CVF = CSF-venous fistula; DSM = digital subtraction myelography; EID = energy integrating detector; FBP = filtered back-projection; SNR = signal-to-noise ratio.

This study aims to develop and evaluate a digital twin (DT) framework to enhance adaptive proton therapy for prostate stereotactic body radiotherapy (SBRT), focusing on improving treatment precision for dominant intraprostatic lesions (DILs) while minimizing organ-at-risk (OAR) toxicity. We propose a decision-theoretic (DT) framework combining deep learning (DL)-based deformable image registration (DIR) with a prior treatment database to generate synthetic CTs (sCTs) for predicting interfractional anatomical changes. Using daily CBCT from five prostate SBRT patients with DILs, the framework precomputes multiple plans with high (DT-H) and low (DT-L) similarity sCTs. Plan optimization is performed in RayStation 2023B, assuming a constant RBE of 1.1 and robustly accounting for positional and range uncertainties. Plan quality is evaluated via a modified ProKnow score across two fractions, with reoptimization limited to 10 minutes. Daily CBCT evaluation showed clinical plans often violated OAR constraints (e.g., bladder V20.8Gy, rectum V23Gy), with DIL V100 < 90% in 2 patients, indicating SIFB failure. DT-H plans, using high-similarity sCTs, achieved better or comparable DIL/CTV coverage and lower OAR doses, with reoptimization completed within 10 min (e.g., DT-H-REopt-A score: 154.3-165.9). DT-L plans showed variable outcomes; lower similarity correlated with reduced DIL coverage (e.g., Patient 4: 84.7%). DT-H consistently outperformed clinical plans within time limits, while extended optimization brought DT-L and clinical plans closer to DT-H quality. This DT framework enables rapid, personalized adaptive proton therapy, improving DIL targeting and reducing toxicity. By addressing geometric uncertainties, it supports outcome gains in ultra-hypofractionated prostate RT and lays groundwork for future multimodal anatomical prediction.

Advances in treatment technology now allow for the use of customizable 3D-printed hydrogel wound dressings for patients with osteoradionecrosis (ORN) of the jaw (ONJ). Meanwhile, deep learning has enabled precise segmentation of 3D medical images using tools like nnUNet. However, the scarcity of labeled data in ONJ imaging makes supervised training impractical. This study aims to develop an unsupervised training approach for automatically identifying anomalies in imaging scans. We propose a novel two-stage training pipeline. In the first stage, a VQ-GAN is trained to accurately reconstruct normal subjects. In the second stage, random cube masking and ONJ-specific masking are applied to train a new encoder capable of recovering the data. The proposed method achieves successful segmentation on both simulated and real patient data. This approach provides a fast initial segmentation solution, reducing the burden of manual labeling. Additionally, it has the potential to be directly used for 3D printing when combined with hand-tuned post-processing.